CORALVILLE, Iowa, Dec. 7 /PRNewswire-FirstCall/ -- Vivakor, Inc. today announced the addition of new Board of Directors members, Dr. Francis Chen and Fritz Lin, M.D.
Fritz Lin, M.D., is a Professor of Clinical Pathology and Interim Chairman of the Department of Pathology and Laboratory Medicine at the University of California, Irvine School of Medicine. He is also the Director of Surgical Pathology & Cytopathology at the UCI Medical Center and is a member of the Chao Family Comprehensive Cancer Center. Dr. Lin is a highly respected clinician and is recognized as a Best Doctor in America by Best Doctors, Inc., an organization that bases its selection on survey results from other physicians. Dr. Lin’s research interests center on the applications of principles of molecular biology, immunohistochemistry and cytometry, and he is playing a key role in the development of a human tumor tissue bank and various frozen tumor tissues for molecular and biological studies.
About Vivakor, Inc.
Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.
CONTACT: Matt Nicosia of Vivakor, Inc., +1-319-625-2172,
mnicosia@vivakor.com
Web site: http://www.vivakor.com/
